Invention Grant
- Patent Title: Deuterated etravirine
-
Application No.: US12288186Application Date: 2008-10-17
-
Publication No.: US08410124B2Publication Date: 2013-04-02
- Inventor: Craig E. Masse
- Applicant: Craig E. Masse
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals Inc.
- Current Assignee: Concert Pharmaceuticals Inc.
- Current Assignee Address: US MA Lexington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D239/02
Abstract:
This disclosure relates to novel di-aryl-pyrimidine (DAPY) compounds and pharmaceutically acceptable salts thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Public/Granted literature
- US20090105147A1 Deuterated etravirine Public/Granted day:2009-04-23
Information query
